2012
DOI: 10.1055/s-0032-1321322
|View full text |Cite
|
Sign up to set email alerts
|

Pyridomycin: Evaluating its antimycobacterial potential through the synthesis and testing of new analogues

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2016
2016
2016
2016

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…The fact that many isoniazide‐resistant clinical isolates of Mycobacterium tuberculosis are sensitive to pyridomycin strongly highlights the efficacy of this drug, thus it has attracted considerable interest from chemists and biologists. For instance, much effort has been made to synthesize the pyridomycin scaffold to resemble the crystal structure of pyridomycin, thereby retaining the ability to bind to InhA and for combined therapy with other compounds …”
Section: Figurementioning
confidence: 99%
“…The fact that many isoniazide‐resistant clinical isolates of Mycobacterium tuberculosis are sensitive to pyridomycin strongly highlights the efficacy of this drug, thus it has attracted considerable interest from chemists and biologists. For instance, much effort has been made to synthesize the pyridomycin scaffold to resemble the crystal structure of pyridomycin, thereby retaining the ability to bind to InhA and for combined therapy with other compounds …”
Section: Figurementioning
confidence: 99%